Investors


Financial Information

PLEXBIO CO., LTD AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME

Items  \  Year2014201520162017 2018
Operating revenue  8,057 6,120 17,13726,55880,987
Gross profit (loss)  1,426  (915) 14,9753,71613,435
Operating expenses  (120,614) (206,523) (191,925)(204,352) (240,215)
Non-operating income and expenses (3,571)  (8,512) (1,930)(16,650)986
Loss before income tax  (124,185)(215,035)(193,855)(221,002)(225,794)
Loss for the year  (124,185)(215,035)(200,242)(221,002)(225,794)
Total comprehensive loss for the year(124,231)(214,388)(202,663)(221,470)(226,983)

Loss attributable to :

Owners of the parent
(124,185)
(215,035)(200,242)(221,002)(225,794)

Comprehensive loss attributable to:

Owners of the parent
  (124,231)(214,388)(202,663)(221,470)(226,983)

Loss per share (in dollars)

Basic loss per share

  (3.33)(5.21)(3.94)(4.35)(3.35)

PLEXBIO CO., LTD AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS

Items  \  Year2014.12.312015.12.312016.12.312017.12.31 2018.12.31
Current assets231,581 407,947 220,693 117,761 227,096
Property, plant and equipment58,96356,27669,41166,37550,264
Intangible assets3,18414,4916,5804,2131,469
Other assets34,52246,68546,71320,92120,921
Total assets328,250525,399343,397209,270299,750
Current Liabilities13,61122,44738,518123,11453,532
Non-current liabilities- - - -5,534

Total liabilities

13,61122,44738,518123,11459,066

Equity attributable to owners of parent

314,639502,952304,87986,156240,684

Share capital

381,370507,845508,585508,585696,085
Capital surplus247,862277,0789,74812,495206,506
Accumulated deficit(315,754)(283,779)(212,841)(433,843)(643,917)
  Other equity interest1,1611,808(613)(1,081)(17,990)
  Total equity314,639502,952304,87986,156240,684